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Abstract: The etiology of motor neuron disease (MND) is still unknown. The aims of this study were
to: (1) analyze MND mortality at a fine-grained level; and (2) explore associations of MND and heavy
metals released into Spanish river basins. MND deaths were extracted from the Spanish nationwide
mortality registry (2007–2016). Standardized mortality ratios (SMRs) for MND were estimated at
a municipal level. Sites that emitted quantities of heavy metals above the regulatory thresholds
were obtained from the European Pollutant Release and Transfer Register database (2007–2015). The
relative risks for non-exposed and exposed municipalities (considering a downstream 20 km river
section) by type of heavy metal were analyzed using a log-linear model. SMRs were significantly
higher in central and northern municipalities. SMRs were 1.14 (1.10–1.17) higher in areas exposed
to heavy metals than in non-exposed areas: 0.95 (0.92–0.96). Considering the different metals,
we found the following increased MND death risks in exposed areas: 20.9% higher risk for lead,
20.0% for zinc, 16.7% for arsenic, 15.7% for chromium, 15.4% for cadmium, 12.7% for copper, and
12.4% for mercury. This study provides associations between MND death risk and heavy metals in
exposed municipalities. Further studies investigating heavy metal exposure are needed to progress
in MND understanding.
Keywords: motor neuron disease; population-based mortality; geographical analysis; heavy metals;
environmental factors
1. Introduction
Motor neuron disease (MND) is a neurodegenerative condition in which motor neuron functions
diminish progressively in the central nervous system [1]. Currently, there is no cure for MND, and no
interventions have been found to stop the progression of symptoms, leading to mortality [2,3]. About
5–10% of MND cases are attributed to familial or genetic origin. Thus, for the remainder of diagnosed
patients, environmental factors may have a key role in the development of the disease [4–8].
Numerous studies have examined the effects that metals have in neurodegenerative diseases,
focusing especially on the role of heavy metals in health [9,10]. Heavy metal exposure has been
associated with amyotrophic lateral sclerosis pathogenesis for more than 150 years, especially since
heavy metals were found in tissues and fluids from MND patients [11].
Despite the lack of a general agreement in defining heavy metals, they are typically referred to as
those chemical elements having a specific density of more than 5 g/cm3 [12]. They are involved in a
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wide range of processes in various receiving environments such as air, soil, or water. Heavy metal
emissions have been continually increasing since the middle of the 19th century at the global level [13].
The association between mercury and MND has been studied, being evident its effects on the
human nervous system, leading to brain alterations or to shyness, tremors, irritability, and changes in
vision or hearing [14]. Lead pollution, described as toxic for more than 100 years, is a major problem in
drinking water pipes in some undeveloped countries, but not in Spain [15]. Chronic exposure to lead
has been linked to mental retardation, birth defects, and brain damage, among others [16,17]. Lead is
one of the most studied heavy metals in terms of exposure and receiving environment, with results
confirming its association with MND [18,19]. Cadmium is a water-soluble heavy metal affecting the
kidney and bones. Chromium is highly persistent in water sediments and, in elevated concentrations,
it is related to ulcers and can induce DNA damage [20]. A case–control study found an association
between cadmium exposure and the occurrence of amyotrophic lateral sclerosis (a type of MND
accounting for the 85% of MND cases) in Catalonia, Spain [21]. Copper toxicity can lead to hepatic
disorders or neurodegenerative changes [22]. Zinc excesses can cause brain damage or affect the
respiratory and gastrointestinal tracts apart from prostate [23], with one of the most common exposing
sources being drinking water [24].
At the same time, an increase of MND death rates has been reported in the past years [25–28].
In Spain, the patterning of MND has been examined, showing geographic variability at the provincial
level, but MND mortality has not been further explored at a finer spatial scale throughout the country,
and few studies including exposure types have been carried out [18,21,28]. Examining the associations
at a more detailed level (e.g., municipality) using geographically referenced environmental data allows
a deeper interrogation of the factors that potentially contribute to MND. If a relationship is found
between increased MND mortality and heavy metal emissions, it will inform future avenues of inquiry
to progress our understanding of MND etiology.
The objectives of this study were to: (1) Analyze the mortality distribution of MND at a municipal
level in a 10-year period; (2) Characterize heavy metal emissions released to river basins; and (3) Explore
associations between heavy metals exposure in water and MND deaths in Spain over a 10-year period.
2. Materials and Methods
Mortality data were extracted from the annual death registry kept by the National Statistics
Institute (NSI) (Instituto Nacional de Estadística), Spain. MND deaths were obtained from 2007 through
2016. These were identified from the International Classification of Diseases, 10th revision, code G12.2,
which included all forms of MND. For Standardized Mortality Ratios (SMRs) and confidence intervals
(CI) calculations, ages were grouped in five-years intervals up to 84 years old and older.
Using the European Pollutant Release and Transfer Register (E-PRTR) database, we extracted
heavy metal quantities released into river basins by emission point in Spain during 2007–2015, and
these were assigned to geographic coordinates provided by this registry [29]. E-PRTR is an information
platform, a register with a list of facilities that have emitted polluting substances exceeding certain
thresholds. This register contains information about the location, emitted substances, quantities
per year, activity, and receiving environment. Facilities are required by law to report the release of
pollutants, and this law is implemented by all EU member countries, which have the task to impose
penalties on sites with emissions beyond the limits in an effective, proportional, and dissuasive way.
Of note, information is only reported by an installation to the E-PRTR when the quantities of pollutants
released exceed certain thresholds.
Heavy metals included in this study were: arsenic, cadmium, copper, chromium, mercury, lead,
and zinc. These heavy metals were selected because there are several studies linking them to MND
symptoms and development [11]. We geocoded the sites that released heavy metal emissions into the
rivers during the mentioned period. Using geographic criteria, we identified a 20 km river section
downstream from the emission point and selected the municipalities that intersected the sections. These
Int. J. Environ. Res. Public Health 2018, 15, 2522 3 of 10
were classified as exposed municipalities. The municipalities that did not intersect these river-sections
were defined as non-exposed municipalities.
We then calculated the times that each emission point had exceeded the thresholds by metal as
indicated by the E-PRTR. The annual limits per emission point and by metal were: mercury 1 kg;
arsenic and cadmium 5 kg; lead 20 kg; chromium and copper 50 kg; Zinc 100 kg [29].
We fitted log-linear models on the assumption that the number of MND deaths per stratum
followed a Poisson distribution. Observed cases were the dependent variable, and expected cases were
included as offset in the models. A term we called “exposure” (distance 20 km or less from the facility)
was included as the independent variable. The regression coefficient of this exposure term gave us
the logarithm of the ratio between the respective mortality ratios for the exposed and reference zones,
which we called incidence report rates (IRR). The advantage of using Poisson regression models is
that they provide a magnitude of association (IRR) and a p-value of global significance between the
exposure variable and mortality.
Statistical analyses were performed using the Stata computer software program, while the
ArcGIS software program (Esri, Redlands, CA, USA) was used for geographic analysis and
cartographic representations.
Research Ethics
The study was conducted in accordance with the Declaration of Helsinki, and the protocol was
approved by the Ethics Committee of the Instituto de Salud Carlos III (CEI 50/2013).
3. Results
There were 9434 deaths due to MND in the period 2007–2016 in the Spanish territory. As shown
in Figure 1a, results obtained for municipal SMRs seemed to be random across the period 2007–2016,
when it was possible to observe both high and low SMRs throughout the national territory. Figure 1b
depicts only significant SMRs, highlighting 90 municipalities. The majority of lower-than-expected
SMRs values (15 municipalities) were located in the southern half of the Spanish territory, whereas the
majority of the higher-than-expected SMRs results (75 municipalities) were located in the northern
half of the country.
We identified 129 sites that reported heavy metal quantities emitted to river basins that exceeded
the thresholds during the period 2007–2015 (Figure 2), noting that a site may release more than one
type of heavy metal. Overall, 92 sites were located in the northern part of Spain, mainly in Basque
Country and Catalonia. Zinc was the most commonly reported exceeding heavy metal emission, whilst
cadmium was the least (99 and 23 sites, respectively). The main activities identified at the sites were:
wastewater treatment sludge, thermal power stations, steel industry, paper industry, and chemical
industry. Overall, 458 municipalities were affected (5.64% of the total Spanish municipalities) as they
intersected 20 km of river downstream from the sites. According to the location of the emission point
for each heavy metal, the number of exposed municipalities varied: zinc n = 382, copper n = 235,
arsenic n = 198, mercury n = 169, lead n = 163, chromium n = 156, and cadmium n=93.
Int. J. Environ. Res. Public Health 2018, 15, 2522 4 of 10
Int. J. Environ. Res. Public Health 2018, 15, x 4 of 10 
 
 
Figure 1. (a) Distribution of standardized mortality ratios (SMRs) due to motor neuron disease (MND) 
from 2007 to 2016. (b) Distribution of lower- and higher-than-expected SMRs. 
Figure 1. (a) Distribution of st n ardized mortality rati Rs) due to motor neuron disease (MND)
from 2007 to 2016. (b) Distribution of lower- and higher-than-expected SMRs.
Int. J. Environ. Res. Public Health 2018, 15, 2522 5 of 10
Int. J. Environ. Res. Public Health 2018, 15, x 5 of 10 
 
 
Figure 2. Location of sites (emission point) releasing heavy metals to river basins in the period 2007–2015 
in Spain. 
The results of the Poisson Regressive Model used to compare mortality due to MND in exposed 
versus non-exposed municipalities is shown in Table 1. Significant SMR differences between the 
exposed and non-exposed municipalities existed. However, SMR attributed to MND was 
significantly higher in exposed municipalities for all metals and for individual metals. The IRR were 
higher in exposed than in non-exposed municipalities (p < 0.001), with an 18.4% increased risk of 
MND for people living in municipalities exposed to heavy metals. MND risk varied by metal 
exposure—lead posed a 20.9% risk (highest), whereas copper and mercury increased the risk by 12.4% 
(lowest). 
Figure 2. Location of sites (emission point) releasing heavy metals to river basins in the period
2007–2015 in Spain.
The results of the Poisson Regressive Model used to compare mortality due to MND in exposed
versus non-exposed municipalities is shown in Table 1. Significant SMR differences between the
expos d and non-exposed municipalities existed. How ver, MR attributed to MND was significantly
higher in exposed municipalities for all metals an for individual metals. The IRR were higher in
exposed than in non-exposed municipalities (p < 0.001), with an 18.4% increased risk of MND for
people living in municipalities exposed to heavy metals. MND risk varied by metal exposure—lead
posed a 20.9% risk (highest), whereas copper and mercury increased the risk by 12.4% (lowest).
Comparing the quantities of heavy metal emissions with the EU regulatory thresholds, we
observed that zinc was the most common substance emitted exceeding its limit (100 kg per year per
site), as shown in Figure 3. Across many emission points, the annual threshold of zinc was exceeded
by more than 100, 200, or even 500 times. Cadmium and lead were the heavy metals least likely to
exceed the regulatory thresholds, with exceeding values measured up to maximum 100 times per year
per site as during the period 2007–2015.
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Table 1. Comparison of motor neuron disease mortality in exposed and non-exposed municipalities based on individual heavy metals: number of deaths (%), SMR,
and incidence report rate (IRR). MND: motor neuron disease SMR: Standardized mortality ratio.
Non-Exposed Municipalities Exposed Municipalities Comparison between Non-Exposed vs. Exposed Municipalities
Deaths from MND (%) SMR Deaths from MND (%) SMR IRR 95% CI p-Value Increased Risk
All heavy metals 6158 (65.27) 0.95 (0.92–0.96) 3276 (34.73) 1.14 (1.10–1.17) 1.184 1.135–1.236 <0.001 18.4%
Arsenic 7348 (77.89) 0.97 (0.95–0.99) 2086 (22.11) 1.13 (1.08–1.18) 1.167 1.112–1225 <0.001 16.7%
Cadmium 8235 (87.29) 0.98 (0.96–1.00) 1199 (12.71) 1.14 (1.07–1.20) 1.154 1.086–1.227 <0.001 15.4%
Chromium 7366 (78.08) 0.97 (0.95–0.99) 2068 (21.92) 1.12 (1.08–1.17) 1.157 1.102–1.215 <0.001 15.7%
Copper 7231 (76.65) 0.97 (0.95–1.00) 2203 (23.35) 1.10 (1.05–1.14) 1.127 1.075–1.182 <0.001 12.7%
Lead 7533 (79.34) 0.97 (0.94–0.99) 1901 (20.66) 1.17 (1.12–1.22) 1.209 1.150–1.271 <0.001 20.9%
Mercury 7397 (78.41) 0.98 (0.95–1.00) 2037 (21.59) 1.10 (1.05–1.15) 1.124 1.071–1.181 <0.001 12.4%
Zinc 6309 (66.88) 0.94(0.92–0.97) 3125 (33.12) 1.13 (1.09–1.17) 1.200 1.150–1.253 <0.001 20.0%
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4. Discussion
This study provides a detailed map of MND mortality in Spain by exploring possible associations
between the MND and heavy metal exposure. The discovery of patterning of significant high and low
mortality rates through the Spanish territory supports a non-randomly spatial distribution of MND.
This spatial pattern is in line with and extends from oth r MND studi s conduc ed at a prov ncial
level [18,28]. The increased MND risk iden ified in certain municipalities cl se to heavy metal e issions
suggests that environmental factors may contribute to MND etiology.
Much research supports the notion of heavy metals being harmful to health, with effects varying
according to dose, duration, exposure conditions, bioavailability, and chemical species [11,30]. Despite
different studies attempting to rank the health effects of specific heavy metals, a consensus has not
been obtained. For example, the U.S. Department of Health and Human Services, Agency for Toxic
Substances and Disease Registry (ATSDR), recognized arsenic, lead and mercury as being the heavy
metals most harmful to human health, on the basis of a combination of frequency and potential
exposure [31]. In relation to specific heavy metals, we found that municipalities exposed to lead had
the highest increased MND risk (20.9%), while those exposed to mercury showed the lowest increased
risk (12.4%) in reference to no -exposed areas.
Although pollutant emission data were available from 2001, we only used data from 2007; in
the period 2001–2007, it was not necessary for emission points to report the exceeding quantities.
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The register was further improved in 2007, with more substances included and a better evaluation
of activities occurring at the sites [32]. The strengths of this study are the potential extension of this
method to include information on other substances and the receiving environment (e.g., air, soil) and
an exhaustive analysis of the activity of sites and the measurements taken after the thresholds were
exceeded. The database from which we extracted the heavy metal emissions data are also available for
other 34 EU countries. The possibility of collecting national MND deaths registries, standardized and
comparable across countries, and the study of heavy metal emissions in a continental context would
provide a large-scale study with large-scale exposure heterogeneity. Identifying associations in a wider
geographic context would be very useful for the European health policy planning and for further
identifying the etiology of and risk factors for MND. Our paper only focuses on the likely effects of
isolated metals on MND mortality and not on the synergistic or antagonistic effects of mixing various
types of metals in water. For instance, there are several articles relating the severe effects in mice of
metals like cadmium combined with fluoride dissolved in water [33]. These possible synergistic effects
should be studied more deeply in the future.
There are limitations in this study. The mortality statistics from NSI did not provide individual
information about personal habits, disease-related genetic history, or occupation. We did not have a
direct measurement of individual exposure to heavy metals. Another limitation is that this registry does
not include information about the possible movement of patients from small to larger municipalities,
once diagnosed, for better treatment. This would imply that MND deaths could be inflated in big
cities, while underestimated in small municipalities. These changes in the municipality of residence
could result in less accuracy when exploring likely associations. However, the population-based and
standardized mortality data used are a noticeable advantage because the registry has national coverage.
Exposure to metals is, in most cases, a long-term process; it would, therefore, be valuable to
have reliable and standardized data about pollutant emissions available for longer time periods (i.e.,
decades). This information could be used to better assess and understand the association between
neurodegenerative diseases and pollutant exposures. It should be noted that sites are not required to
report quantity emissions when they do not exceed the set threshold; therefore, when we found a gap
in a year information in one emission point in the studied period, it could mean two things: a released
quantity lower than the limit or no emission produced. The absence of data seems to indicate that, in
the event of heavy metal release, this would not involve a health hazard. Finally, it is important to
note that this is emergent research that needs to be analyzed with greater precision in future studies,
especially as regards the interaction of heavy metals with the rivers where they are released in terms
of dissolution of substances in water and hydraulic flow of each river, and the study of multiple
cross-sectional distances from the emission points.
While this study does not definitively link heavy metal exposure to MND, it identifies a valid
approach and further lines of inquiry. Within a national context, this is a novel study which indicates
characteristics of MND mortality and heavy metals that suggest further investigations at a local level,
considering river characteristics and the behaviors of the different heavy metal in rivers.
5. Conclusions
In conclusion, we described the detailed mortality rates due to MND during 10 years in
Spain, finding patterns that indicate higher rates than expected of MND in northern municipalities.
Also, we explored heavy metal emissions in river basins, identifying emission points exceeding
the recommended thresholds predominantly located in northern areas. Increased MND mortality
risk in the exposed areas was shown when analyzing heavy metals individually and together. This
investigation underscores the value of combining geographic and epidemiologic techniques for the
understanding of the patterning of relationships between rare diseases and environmental exposures.
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